Reflecting on Early Arthritis

> “To become a man is to be responsible; to be ashamed of miseries that you did not cause.” > > — Antoine de Saint-Exupery1 I recently returned from a much-anticipated Hawaiian vacation. During the lengthy plane ride, I had time to relax and reflect. I thought about the provocative work by Tavares, et al , showing that only 41% of patients with rheumatoid arthritis (RA) were started on therapy within 6 months of presumed onset of disease, and that 78% of the delay was attributable to processes/events that occurred before the patients ever saw a rheumatologist2. I thought about the excellent literature review categorizing delays of diagnosis and treatment by time from symptoms to assessment by a primary care physician (PCP), from PCP to rheumatology referral and then assessment, and finally to commencement of disease-modifying antirheumatic drug therapy3. I thought about a patient from a few months ago — an otherwise healthy young woman with palindromic arthritis following a sore throat, whose symptoms quickly and fully resolved; I suspected her illness likely viral and transient in nature4, even though she had mentioned some prior complaints that were suspicious, but not definitive, for RA. Antibodies to anticitrullinated protein and rheumatoid factor had been measured and were positive. How do I classify and treat this patient? I thought about this patient’s relative good fortune in having ready access to expert care in contrast to those, for example, at … Address correspondence to Dr. R. Panush, 2011 Zonal Ave., HMR 711, Keck School of Medicine, USC, Los Angeles, CA 90032, USA. E-mail: panush{at}usc.edu

[1]  A. Silman,et al.  A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis , 2012, Annals of the rheumatic diseases.

[2]  A. Laupacis,et al.  Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort , 2012, The Journal of Rheumatology.

[3]  D. Berwick A piece of my mind. To Isaiah. , 2012, JAMA.

[4]  R. Panush,et al.  Early arthritis: a race to the starting line. , 2012, Rheumatic diseases clinics of North America.

[5]  R. Panush,et al.  Epilogue: how will we care for patients with early arthritis? , 2012, Rheumatic diseases clinics of North America.

[6]  Jeffrey R Curtis,et al.  2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis , 2012, Arthritis care & research.

[7]  J. Katz,et al.  Use of disease‐modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey , 2012, Arthritis care & research.

[8]  Y. van Eijk-Hustings,et al.  EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis , 2011, Annals of the rheumatic diseases.

[9]  J. Smolen,et al.  Immediate access rheumatology clinic: efficiency and outcomes , 2011, Annals of the rheumatic diseases.

[10]  R. Panush,et al.  Later Comes Earlier, Nowadays , 2011, The Journal of Rheumatology.

[11]  J. Imboden,et al.  Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university‐affiliated clinics , 2011, Arthritis care & research.

[12]  P. Adam,et al.  Everyday ethics and help-seeking in early rheumatoid arthritis , 2010, Chronic illness.

[13]  John Wong,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs , 2010, Annals of the rheumatic diseases.

[14]  K. Nishimura,et al.  [New biomarkers for rheumatoid arthritis]. , 2008, Rinsho byori. The Japanese journal of clinical pathology.

[15]  J. Jacobs,et al.  Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) , 2007, Annals of the rheumatic diseases.

[16]  B. Hardman A piece of mind , 2004 .

[17]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[18]  L. Witts Year Book of Medicine , 1948 .